Just Healthcare

Just Healthcare

Share this post

Just Healthcare
Just Healthcare
Heart Surgery Still Beats Stents Despite New Study Findings
Copy link
Facebook
Email
Notes
More

Heart Surgery Still Beats Stents Despite New Study Findings

A critical look at the endpoint adjustments (changes in how researchers measured outcomes) in the FAME 3 trial and their impact on coronary artery disease treatment guidelines.

Naveen Sankar S's avatar
Naveen Sankar S
May 18, 2025
∙ Paid

Share this post

Just Healthcare
Just Healthcare
Heart Surgery Still Beats Stents Despite New Study Findings
Copy link
Facebook
Email
Notes
More
Share

Topline:

Despite changes to the outcomes measured that altered conclusions in recent reports, the 5-year results of the FAME 3 trial confirm coronary artery bypass graft surgery (CABG) remains superior to percutaneous coronary intervention (PCI) with stents for multivessel coronary artery disease (CAD).

Study Details:

The FAME 3 trial initially aimed to …

Keep reading with a 7-day free trial

Subscribe to Just Healthcare to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 Just Healthcare
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More